Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled study of D-2570 induction therapy in moderate to severe active ulcerative colitis
CTR20251691Phase 2Active
- Sponsor
- InventisBio
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of D-2570 in autoimmune colitis, sponsored by InventisBio. Started May 2025; status: active.
02
Drugs
D-2570
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20251691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251691.